What is Zacks Research’s Forecast for Teleflex Q1 Earnings?

Teleflex Incorporated (NYSE:TFX) – Analysts at Zacks Research reduced their Q1 2025 earnings estimates for shares of Teleflex in a note issued to investors on Thursday, March 6th. Zacks Research analyst R. Department now expects that the medical technology company will earn $2.77 per share for the quarter, down from their previous estimate of $3.51. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s FY2025 earnings at $14.04 EPS, Q1 2026 earnings at $3.45 EPS and FY2026 earnings at $14.97 EPS.

TFX has been the subject of several other reports. Royal Bank of Canada cut shares of Teleflex from an “outperform” rating to a “sector perform” rating and decreased their price objective for the company from $220.00 to $155.00 in a report on Friday, February 28th. Wells Fargo & Company reduced their target price on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a report on Friday, February 28th. Citizens Jmp cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Finally, Bank of America cut shares of Teleflex from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $182.63.

Teleflex Trading Up 0.6 %

Teleflex stock opened at $139.25 on Monday. The firm has a 50 day simple moving average of $169.58 and a 200-day simple moving average of $199.60. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a market capitalization of $6.46 billion, a PE ratio of 27.68, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. Teleflex has a 12-month low of $128.55 and a 12-month high of $249.90.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million.

Institutional Investors Weigh In On Teleflex

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Headlands Technologies LLC purchased a new stake in Teleflex in the 4th quarter worth approximately $29,000. Avior Wealth Management LLC lifted its position in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after buying an additional 101 shares in the last quarter. Ashton Thomas Securities LLC purchased a new stake in Teleflex in the 3rd quarter worth approximately $40,000. True Wealth Design LLC lifted its position in Teleflex by 16,600.0% in the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after buying an additional 166 shares in the last quarter. Finally, Capital Performance Advisors LLP purchased a new stake in Teleflex in the 3rd quarter worth approximately $54,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be given a $0.34 dividend. The ex-dividend date is Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 0.98%. Teleflex’s payout ratio is 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.